Cyclacel Pharma (CYCC) Gets Orphan Drug Designation from U.S. FDA for CYC682 AML and MDS Treatment
Tweet Send to a Friend
Cyclacel Pharmaceuticals, Inc. (Nasdaq: CYCC) (Nasdaq: CYCCP) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
